{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:59:05Z","timestamp":1790855945574,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"DOI":"10.1007\/s12105-024-01627-4","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T13:03:37Z","timestamp":1711544617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Expression Profile of Circulating Exosomal microRNAs in Leukoplakia, Oral Submucous Fibrosis, and Combined Lesions of Leukoplakia and Oral Submucous Fibrosis"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5535-0356","authenticated-orcid":false,"given":"Dinesh","family":"Yasothkumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5426-3506","authenticated-orcid":false,"given":"Pratibha","family":"Ramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selvaraj","family":"Jayaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karthikeyan","family":"Ramalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. M.","family":"Tilakaratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,27]]},"reference":[{"key":"1627_CR1","doi-asserted-by":"crossref","first-page":"208519","DOI":"10.1155\/2015\/208519","volume":"2015","author":"S Kumar","year":"2015","unstructured":"Kumar S et al (2015) Prevalence and risk factors for oral potentially malignant disorders in Indian population. Adv Prev Med 2015:208519","journal-title":"Adv Prev Med"},{"key":"1627_CR2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/hed.26006","volume":"42","author":"O Iocca","year":"2020","unstructured":"Iocca O et al (2020) Potentially malignant disorders of the oral cavity and oral dysplasia: a systematic review and meta-analysis of malignant transformation rate by subtype. Head Neck 42:539\u2013555","journal-title":"Head Neck"},{"key":"1627_CR3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/0970-9290.80009","volume":"22","author":"B Sabarinath","year":"2011","unstructured":"Sabarinath B, Sriram G, Saraswathi TR, Sivapathasundharam B (2011) Immunohistochemical evaluation of mast cells and vascular endothelial proliferation in oral submucous fibrosis. Indian J Dent Res 22:116\u2013121","journal-title":"Indian J Dent Res"},{"key":"1627_CR4","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.3390\/ijms20122940","volume":"20","author":"Y-H Shih","year":"2019","unstructured":"Shih Y-H, Wang T-H, Shieh T-M, Tseng Y-H (2019) Oral submucous fibrosis: a review on etiopathogenesis, diagnosis, and therapy. Int J Mol Sci 20:2940","journal-title":"Int J Mol Sci"},{"key":"1627_CR5","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1600-0714.2009.00804.x","volume":"38","author":"G Pitiyage","year":"2009","unstructured":"Pitiyage G, Tilakaratne WM, Tavassoli M, Warnakulasuriya S (2009) Molecular markers in oral epithelial dysplasia: review. J Oral Pathol Med 38:737\u2013752","journal-title":"J Oral Pathol Med"},{"key":"1627_CR6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.oraloncology.2019.07.003","volume":"97","author":"D Lauritano","year":"2019","unstructured":"Lauritano D et al (2019) Liquid biopsy in head and neck squamous cell carcinoma: prognostic significance of circulating tumor cells and circulating tumor DNA. A systematic review. Oral Oncol 97:7\u201317","journal-title":"Oral Oncol"},{"key":"1627_CR7","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1080\/14737159.2020.1855977","volume":"20","author":"W-Y Yang","year":"2020","unstructured":"Yang W-Y et al (2020) Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes. Expert Rev Mol Diagn 20:1213\u20131227","journal-title":"Expert Rev Mol Diagn"},{"key":"1627_CR8","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3390\/ijms21041197","volume":"21","author":"T Yap","year":"2020","unstructured":"Yap T et al (2020) Extracellular vesicles in oral squamous cell carcinoma and oral potentially malignant disorders: a systematic review. Int J Mol Sci 21:1197","journal-title":"Int J Mol Sci"},{"key":"1627_CR9","first-page":"1","volume-title":"Diagnostic and Therapeutic Applications of Exosomes in Cancer","author":"PB Munson","year":"2018","unstructured":"Munson PB, Shukla A (2018) Introduction to exosomes and cancer. Diagnostic and Therapeutic Applications of Exosomes in Cancer. Academic Press, London, pp 1\u201310"},{"key":"1627_CR10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/B978-0-12-812774-2.00010-9","volume-title":"Diagnostic and Therapeutic Applications of Exosomes in Cancer","author":"LG Lima","year":"2018","unstructured":"Lima LG, M\u00f6ller A (2018) Biodistribution of cancer-derived exosomes. Diagnostic and Therapeutic Applications of Exosomes in Cancer. Academic Press, London, pp 175\u2013186"},{"key":"1627_CR11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/B978-0-12-812774-2.00009-2","volume-title":"Diagnostic and Therapeutic Applications of Exosomes in Cancer","author":"P Hochendoner","year":"2018","unstructured":"Hochendoner P, Zhao Z, He M (2018) Diagnostic potential of tumor exosomes. Diagnostic and Therapeutic Applications of Exosomes in Cancer. Academic Press, London, pp 161\u20131735"},{"key":"1627_CR12","volume":"9","author":"Y Lu","year":"2021","unstructured":"Lu Y et al (2021) The emerging role of exosomes in oral squamous cell carcinoma. Front Cell Dev Biol 9:628103","journal-title":"Front Cell Dev Biol"},{"key":"1627_CR13","doi-asserted-by":"crossref","first-page":"38750","DOI":"10.1038\/srep38750","volume":"6","author":"S Sakha","year":"2016","unstructured":"Sakha S, Muramatsu T, Ueda K, Inazawa J (2016) Exosomal microRNA miR-1246 induces cell motility and invasion through the regulation of DENND2D in oral squamous cell carcinoma. Sci Rep 6:38750","journal-title":"Sci Rep"},{"key":"1627_CR14","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.3390\/ijms21114072","volume":"21","author":"L Hofmann","year":"2020","unstructured":"Hofmann L et al (2020) The emerging role of exosomes in diagnosis, prognosis, and therapy in head and neck cancer. Int J Mol Sci 21:4072","journal-title":"Int J Mol Sci"},{"key":"1627_CR15","doi-asserted-by":"crossref","first-page":"FSO465","DOI":"10.2144\/fsoa-2019-0116","volume":"6","author":"N Dilsiz","year":"2020","unstructured":"Dilsiz N (2020) Role of exosomes and exosomal microRNAs in cancer. Future Sci OA 6:FSO465","journal-title":"Future Sci OA"},{"key":"1627_CR16","volume":"7","author":"A Gallo","year":"2012","unstructured":"Gallo A, Tandon M, Alevizos I, Illei GG (2012) The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS ONE 7:e30679","journal-title":"PLoS ONE"},{"key":"1627_CR17","unstructured":"Sempere LF (2019) MicroRNA as biomarkers in cancer diagnostics and therapy"},{"key":"1627_CR18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/tcmj.tcmj_114_17","volume":"30","author":"TNU Maheswari","year":"2018","unstructured":"Maheswari TNU, Venugopal A, Sureshbabu NM, Ramani P (2018) Salivary micro RNA as a potential biomarker in oral potentially malignant disorders: a systematic review. Tzu Chi Med J 30:55\u201360","journal-title":"Tzu Chi Med J"},{"key":"1627_CR19","doi-asserted-by":"crossref","first-page":"6821","DOI":"10.1093\/nar\/gks308","volume":"40","author":"J Ribas","year":"2012","unstructured":"Ribas J et al (2012) A novel source for miR-21 expression through the alternative polyadenylation of VMP1 gene transcripts. Nucleic Acids Res 40:6821\u20136833","journal-title":"Nucleic Acids Res"},{"key":"1627_CR20","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.767064","volume":"8","author":"S Surina","year":"2021","unstructured":"Surina S et al (2021) miR-21 in human cardiomyopathies. Front Cardiovasc Med 8:767064","journal-title":"Front Cardiovasc Med"},{"key":"1627_CR21","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.1158\/0008-5472.CAN-05-0137","volume":"65","author":"JA Chan","year":"2005","unstructured":"Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65:6029\u20136033","journal-title":"Cancer Res"},{"key":"1627_CR22","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1158\/1078-0432.CCR-07-0666","volume":"14","author":"T-S Wong","year":"2008","unstructured":"Wong T-S et al (2008) Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 14:2588\u20132592","journal-title":"Clin Cancer Res"},{"key":"1627_CR23","first-page":"130","volume":"9","author":"T-S Wong","year":"2009","unstructured":"Wong T-S, Ho W-K, Chan JY-W, Ng RW-M, Wei WI (2009) Mature miR-184 and squamous cell carcinoma of the tongue. SciWorldJ 9:130\u2013132","journal-title":"SciWorldJ"},{"key":"1627_CR24","first-page":"2221","volume":"16","author":"D Chen","year":"2018","unstructured":"Chen D et al (2018) miR-184 promotes cell proliferation in tongue squamous cell carcinoma by targeting SOX7. Oncol Lett 16:2221\u20132228","journal-title":"Oncol Lett"},{"key":"1627_CR25","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1073\/pnas.0808042106","volume":"106","author":"M Sachdeva","year":"2009","unstructured":"Sachdeva M et al (2009) p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc Natl Acad Sci U S A 106:3207\u20133212","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1627_CR26","first-page":"882","volume":"1","author":"MZ Michael","year":"2003","unstructured":"Michael MZ, O\u2019Connor SM, van Holst Pellekaan NG, Young GP, James RJ (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1:882\u2013891","journal-title":"Mol Cancer Res"},{"key":"1627_CR27","doi-asserted-by":"crossref","first-page":"4806","DOI":"10.1038\/onc.2012.495","volume":"32","author":"A Pagliuca","year":"2013","unstructured":"Pagliuca A et al (2013) Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression. Oncogene 32:4806\u20134813","journal-title":"Oncogene"},{"key":"1627_CR28","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1111\/odi.13704","volume":"27","author":"S Warnakulasuriya","year":"2020","unstructured":"Warnakulasuriya S et al (2020) Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis 27:1862\u20131880","journal-title":"Oral Dis"},{"key":"1627_CR29","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.oraloncology.2008.05.018","volume":"45","author":"S Petti","year":"2009","unstructured":"Petti S (2009) Lifestyle risk factors for oral cancer. Oral Oncol 45:340\u2013350","journal-title":"Oral Oncol"},{"key":"1627_CR30","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/jop.12726","volume":"47","author":"FW Mello","year":"2018","unstructured":"Mello FW et al (2018) Prevalence of oral potentially malignant disorders: a systematic review and meta-analysis. J Oral Pathol Med 47:633\u2013640","journal-title":"J Oral Pathol Med"},{"key":"1627_CR31","doi-asserted-by":"crossref","first-page":"8261","DOI":"10.1038\/s41598-022-12441-9","volume":"12","author":"TT Nevanp\u00e4\u00e4","year":"2022","unstructured":"Nevanp\u00e4\u00e4 TT, Ter\u00e4v\u00e4 AE, Laine HK, Rautava J (2022) Malignant transformation of oral epithelial dysplasia in Southwest Finland. Sci Rep 12:8261","journal-title":"Sci Rep"},{"key":"1627_CR32","first-page":"1793","volume":"11","author":"V Murthy","year":"2022","unstructured":"Murthy V et al (2022) Malignant transformation rate of oral submucous fibrosis: a systematic review and meta-analysis. J Clin Med Res 11:1793","journal-title":"J Clin Med Res"},{"key":"1627_CR33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4103\/jdmimsu.jdmimsu_40_18","volume":"13","author":"A Hande","year":"2018","unstructured":"Hande A et al (2018) Role of hypoxia in malignant transformation of oral submucous fibrosis. J Datta Meghe Inst Med Sci Univ 13:38","journal-title":"J Datta Meghe Inst Med Sci Univ"},{"key":"1627_CR34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jebdp.2013.10.009","volume":"13","author":"MWS Ho","year":"2013","unstructured":"Ho MWS (2013) Patients with both oral leukoplakia and oral submucous fibrosis had a higher rate of malignant transformation compared to patients with oral leukoplakia or oral submucous fibrosis alone. J Evid Based Dent Pract 13:183\u2013184","journal-title":"J Evid Based Dent Pract"},{"key":"1627_CR35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.2041-1626.2011.00055.x","volume":"2","author":"PR Jayasooriya","year":"2011","unstructured":"Jayasooriya PR, Nadeeka Jayasinghe KA, Mudiyanselage Tilakaratne W (2011) Relationship between thickness of fibrosis and epithelial dysplasia in oral submucous fibrosis. J Investig Clin Dent 2:171\u2013175","journal-title":"J Investig Clin Dent"},{"key":"1627_CR36","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.3748\/wjg.v19.i20.2985","volume":"19","author":"J Raisch","year":"2013","unstructured":"Raisch J, Darfeuille-Michaud A, Nguyen HTT (2013) Role of microRNAs in the immune system, inflammation and cancer. World J Gastroenterol 19:2985\u20132996","journal-title":"World J Gastroenterol"},{"key":"1627_CR37","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/odi.12340","volume":"21","author":"F Zahran","year":"2015","unstructured":"Zahran F, Ghalwash D, Shaker O, Al-Johani K, Scully C (2015) Salivary microRNAs in oral cancer. Oral Dis 21:739\u2013747","journal-title":"Oral Dis"},{"key":"1627_CR38","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.3390\/ijerph19063396","volume":"19","author":"M Dioguardi","year":"2022","unstructured":"Dioguardi M et al (2022) MicroRNA-21 expression as a prognostic biomarker in oral cancer: systematic review and meta-analysis. Int J Environ Res Public Health 19:3396","journal-title":"Int J Environ Res Public Health"},{"key":"1627_CR39","volume":"7","author":"M Han","year":"2012","unstructured":"Han M et al (2012) Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT\/ERK1\/2 inactivation by targeting PTEN. PLoS ONE 7:e39520","journal-title":"PLoS ONE"},{"key":"1627_CR40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11010-012-1443-3","volume":"372","author":"Z-L Liu","year":"2013","unstructured":"Liu Z-L, Wang H, Liu J, Wang Z-X (2013) MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN. Mol Cell Biochem 372:35\u201345","journal-title":"Mol Cell Biochem"},{"key":"1627_CR41","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1038\/sj.onc.1210856","volume":"27","author":"IA Asangani","year":"2008","unstructured":"Asangani IA et al (2008) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27:2128\u20132136","journal-title":"Oncogene"},{"key":"1627_CR42","doi-asserted-by":"crossref","first-page":"19300","DOI":"10.1073\/pnas.0803992105","volume":"105","author":"J Yu","year":"2008","unstructured":"Yu J et al (2008) MicroRNA-184 antagonizes microRNA-205 to maintain SHIP2 levels in epithelia. Proc Natl Acad Sci U S A 105:19300\u201319305","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1627_CR43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/onc.2012.28","volume":"32","author":"J Zhang","year":"2013","unstructured":"Zhang J et al (2013) Loss of microRNA-143\/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop. Oncogene 32:61\u201369","journal-title":"Oncogene"},{"key":"1627_CR44","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3892\/or.2012.1645","volume":"27","author":"BG Zhang","year":"2012","unstructured":"Zhang BG et al (2012) microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol Rep 27:1019\u20131026","journal-title":"Oncol Rep"},{"key":"1627_CR45","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12253-013-9689-y","volume":"20","author":"A Kawakita","year":"2014","unstructured":"Kawakita A et al (2014) MicroRNA-21 promotes oral cancer invasion via the Wnt\/\u03b2-catenin pathway by targeting DKK2. Pathol Oncol Res 20:253\u2013261","journal-title":"Pathol Oncol Res"},{"key":"1627_CR46","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1755-5949.2012.00344.x","volume":"18","author":"L Han","year":"2012","unstructured":"Han L et al (2012) MicroRNA-21 expression is regulated by \u03b2-catenin\/STAT3 pathway and promotes glioma cell invasion by direct targeting RECK. CNS Neurosci Ther 18:573\u2013583","journal-title":"CNS Neurosci Ther"},{"key":"1627_CR47","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.oraloncology.2014.06.005","volume":"50","author":"MA Gonz\u00e1lez-Moles","year":"2014","unstructured":"Gonz\u00e1lez-Moles MA, Ruiz-\u00c1vila I, Gil-Montoya JA, Plaza-Campillo J, Scully C (2014) \u03b2-catenin in oral cancer: an update on current knowledge. Oral Oncol 50:818\u2013824","journal-title":"Oral Oncol"},{"key":"1627_CR48","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3892\/etm.2021.9804","volume":"21","author":"Z Xin","year":"2021","unstructured":"Xin Z, Tong Z, Tan J, Liu C (2021) MicroRNA-145-5p aggravates cell apoptosis and oxidative stress in tongue squamous cell carcinoma. Exp Ther Med 21:373","journal-title":"Exp Ther Med"},{"key":"1627_CR49","doi-asserted-by":"crossref","first-page":"e002","DOI":"10.1590\/1807-3107bor-2020.vol34.0002","volume":"34","author":"TN Uma Maheswari","year":"2020","unstructured":"Uma Maheswari TN, Nivedhitha MS, Ramani P (2020) Expression profile of salivary micro RNA-21 and 31 in oral potentially malignant disorders. Braz Oral Res 34:e002","journal-title":"Braz Oral Res"},{"key":"1627_CR50","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2174\/2211536609666200127143749","volume":"9","author":"SR Prasad","year":"2020","unstructured":"Prasad SR, Pai A, Shyamala K, Yaji A (2020) Expression of salivary miRNA 21 in oral submucous fibrosis (OSMF): an observational study. Microrna 9:295\u2013302","journal-title":"Microrna"},{"key":"1627_CR51","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.3390\/biom11121879","volume":"11","author":"N Kaunein","year":"2021","unstructured":"Kaunein N et al (2021) A systematic review of MicroRNA signatures associated with the progression of leukoplakia with and without epithelial dysplasia. Biomolecules 11:1879","journal-title":"Biomolecules"},{"key":"1627_CR52","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1093\/hmg\/ddp446","volume":"18","author":"NK Cervigne","year":"2009","unstructured":"Cervigne NK et al (2009) Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum Mol Genet 18:4818\u20134829","journal-title":"Hum Mol Genet"},{"key":"1627_CR53","volume":"120","author":"C-M Chen","year":"2021","unstructured":"Chen C-M et al (2021) Exosome-derived microRNAs in oral squamous cell carcinomas impact disease prognosis. Oral Oncol 120:105402","journal-title":"Oral Oncol"},{"key":"1627_CR54","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/hed.26089","volume":"42","author":"AJ Yoon","year":"2020","unstructured":"Yoon AJ et al (2020) MicroRNA-based risk scoring system to identify early-stage oral squamous cell carcinoma patients at high-risk for cancer-specific mortality. Head Neck 42:1699\u20131712","journal-title":"Head Neck"},{"key":"1627_CR55","first-page":"1408","volume":"35","author":"N Mahmood","year":"2019","unstructured":"Mahmood N et al (2019) Circulating miR-21 as a prognostic and predictive biomarker in oral squamous cell carcinoma. Pak J Med Sci Q 35:1408\u20131412","journal-title":"Pak J Med Sci Q"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-024-01627-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12105-024-01627-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-024-01627-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T15:21:26Z","timestamp":1736349686000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12105-024-01627-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,27]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1627"],"URL":"https:\/\/doi.org\/10.1007\/s12105-024-01627-4","relation":{},"ISSN":["1936-0568"],"issn-type":[{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,27]]},"assertion":[{"value":"13 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no financial or non-financial interests that are directly or indirectly related to the work submitted for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Consent for publication was obtained for every individual person\u2019s data included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}],"article-number":"28"}}